Xconomy National

Archives

by in

Entry	Author	Date	Location
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy	Bruce V. Bigelow	02/03/12	San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News	Erin Kutz	02/03/12	Boston
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug	Luke Timmerman	01/27/12	National
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2)	Luke Timmerman	11/22/11	National
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News	Bruce V. Bigelow	11/10/11	San Diego
Unlimited Abilities: A View from the MedtechVision Conference	Lisa Suennen	09/27/11	San Francisco
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News	Erin Kutz	08/12/11	Boston
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News	Bruce V. Bigelow	08/11/11	San Diego
Bydureon FDA Deadline Set	Luke Timmerman	08/10/11	San Diego
Amylin & Takeda Halt Obesity Drug Development	Bruce V. Bigelow	08/04/11	San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
Bydureon Sent Back to FDA	Luke Timmerman	07/28/11	San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News	Bruce V. Bigelow	07/28/11	San Diego
Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA	Luke Timmerman	07/07/11	San Diego
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech”	Luke Timmerman	07/06/11	Boston
Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News	Bruce V. Bigelow	06/30/11	San Diego
A San Diego Sampler from the War on Diabetes	Bruce V. Bigelow	06/24/11	San Diego
Inception 1 Raises $5M, VCs Pessimistic About U.S. Biotech Funding, EU Approves Amylin’s Once-a-Week Diabetes Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	06/23/11	San Diego
Amylin, Alkermes Diabetes Med OKd in EU	Luke Timmerman	06/21/11	San Diego
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News	Bruce V. Bigelow	06/09/11	San Diego
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News	Bruce V. Bigelow	06/02/11	San Diego
Shire Pays $750M for Advanced BioHealing, Amylin Sues Lilly, Pacira CEO Describes His Most Difficult Task, & More San Diego Life Sciences News	Bruce V. Bigelow	05/19/11	San Diego
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug	Luke Timmerman	05/16/11	San Diego
Halozyme Deal Could Yield $83M, Wireless Health Leaders Converge, Readers Vote on Worst Drug Names, & More San Diego Life Sciences News	Bruce V. Bigelow	05/12/11	San Diego
Alkermes Acquires Elan Drug Manufacturing Unit for $960M	Luke Timmerman	05/09/11	Boston
CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication	Luke Timmerman	04/18/11	San Diego
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug	Luke Timmerman	04/15/11	San Diego
Amylin Suspends Obesity Drug Development, Sapphire Energy Partners with Monsanto, 23andMe Gets Connected to UCSD’s Fowler, & More San Diego Life Sciences News	Bruce V. Bigelow	03/17/11	San Diego
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News	Erin Kutz	03/04/11	Boston
Page 1 of 5	next page »